Related Experiment Video
Updated: Jun 15, 2025
05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
Cytotoxic and Antitumor Agents from Genus Rubia
Geng Xu1, Meiyu Liu2, Zuobin Wang1,2,3
1School of Life Sciences, Changchun University of Science and Technology, Changchun, 130022, China.
Chemistry & Biodiversity
|August 25, 2024
Summary
This review explores the anticancer potential of Rubia species, highlighting 71 chemical compounds with cytotoxic and antitumor effects. These findings support the use of Rubia in traditional medicine for cancer treatment.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Oncology
Background:
- Genus Rubia, including Rubia cordifolia, has a long history of use in Traditional Chinese Medicine.
- Recent research indicates Rubia extracts possess cytotoxic and antitumor properties.
- Identifying specific antitumor agents within Rubia species is an active area of investigation.
Purpose of the Study:
- To review the cytotoxic and antitumor effects of chemical constituents from the Genus Rubia.
- To consolidate information on the structures, targets, and mechanisms of action of these compounds.
Main Methods:
- Literature review of studies on Rubia species and their chemical constituents.
- Categorization of identified chemical substances based on their biological activity.
- Analysis of structural and mechanistic data for compounds exhibiting cytotoxicity and antitumor effects.
Main Results:
- Identified and summarized 71 chemical substances from Genus Rubia with cytotoxic and antitumor activities.
- Classified these compounds into 5 major categories.
- Detailed their structures, biological targets, and mechanisms of action.
Conclusions:
- Chemical constituents of Genus Rubia demonstrate significant cytotoxic and antitumor potential.
- This review provides a comprehensive overview of these compounds, supporting further research into Rubia-derived anticancer agents.
- Findings validate the traditional medicinal use of Rubia species for treating diseases, particularly cancer.
More Related Videos
Related Concept Videos
01:10Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493